Somalia's Ebola preparedness and cross-border risk following the recent 2025 DRC outbreak. [PDF]
New Microbes New InfectAli AS, Ahmed MM.
europepmc +1 more source
Achievements and Challenges in Therapy and Vaccines Development of Viral Hemorrhagic Fevers: An Up-to-Date Review. [PDF]
PharmaceuticsLupascu D +8 more
europepmc +1 more source
Congo's conflicts, minerals and microbes: planetary health implications. [PDF]
BMJ Glob HealthEbrahim SH +5 more
europepmc +1 more source
Development of VP30-targeted nanoparticles using DPS4 fusion peptides for the inhibition of Ebola virus. [PDF]
J NanobiotechnologyWu F +10 more
europepmc +1 more source
Infection prevention and control measures for Ebola disease and their outcomes from the perspective of health care workers: a mixed-methods study. [PDF]
BMC Public HealthHonein-AbouHaidar G +7 more
europepmc +1 more source
Oral immunization with filovirus-like particles partially protects IFNAR<sup>-</sup>/<sup>-</sup> mice against lethal ebola virus challenge. [PDF]
Sci RepEscudero-Pérez B +11 more
europepmc +1 more source
Qualitative exploration of COVID-19 vaccine uptake among healthcare workers in Sierra Leone: do the 'trusted messengers' trust the vaccine? [PDF]
BMJ Public HealthDavid I, Schatz E, Majee W.
europepmc +1 more source
Readiness of health public facilities to diagnose, manage, and prevent the Ebola epidemic along border districts in Southwestern Uganda. [PDF]
BMC Health Serv ResSserunkuuma J +6 more
europepmc +1 more source
Evidence for Neuroinvasive Lassa Virus Infection in Pediatric Patients: Initial Findings and Implications. [PDF]
J Infect DisPlatt AP, Chertow DS.
europepmc +1 more source
From Nipah virus disease to disease X: Vigilance against the "infodemic". [PDF]
Infect Med (Beijing)Sun J, Wang G.
europepmc +1 more source